The Science Behind Greta’s Personalized Cancer Vaccine
What if we could teach Greta’s immune system what her cancer looks like?
Cancer treatment has traditionally been based largely on where a cancer starts and what type of cancer it is.
But we now know that cancers that share the same diagnosis can be biologically different.
Greta’s tumor contains its own genetic and molecular information. By studying that information, researchers can look for characteristics of her cancer that may be useful as targets for her immune system.
That creates the possibility of a treatment designed not simply for ependymoma but for Greta’s ependymoma.
From Greta's tumor to a treatment built for her
How a personalized cancer vaccine comes together.
The process begins with information already contained inside Greta's own tumor and asks whether that information can be turned into a treatment designed specifically for her cancer.
Tumor tissue is analyzed to better understand the genetic and molecular characteristics of Greta's cancer.
Researchers use that data to identify potential features of the tumor that may be useful targets for an immune response.
Selected targets can be used to design a personalized mRNA vaccine specifically around Greta's tumor.
The individualized vaccine must be manufactured and undergo appropriate quality and safety testing.
Clinical and regulatory requirements must be addressed before an investigational treatment can be given.
If authorized and medically appropriate, the vaccine could be administered and Greta's response closely monitored.
The goal: help Greta's immune system learn what her cancer looks like — and recognize it when it sees it.
This illustration simplifies a highly complex process. A personalized mRNA vaccine for Greta would be investigational, the exact pathway and timing may change, and there is no guarantee that the treatment will be successful.